[Edaily Reporter Hyera Lee ] #ViolMedical unveiled a new advertising campaign on the 3rd for its high-intensity focused ultrasound (HIFU) lifting device, DUOTITE, featuring brand ambassador Shin Hye-sun. Viol Medical’s DUOTITE advertising campaign. (Photo courtesy of Viol Medical)
With “What’s your type? Dual Type” as its core message, this campaign intuitively conveys the two-pronged care approach offered by DUOTITE and visually embodies the concept of “sculpted lifting.” DuoTight is an HIFU lifting device that delivers thermal energy at various depths, from the superficial musculoaponeurotic system (SMAS) layer to the dermis. It is designed to target different depths with a single cartridge, thereby enhancing treatment efficiency and ease of use. The campaign video begins with Shin Hye-sun appearing on stage. It conveys the value of DuoTight’s “Sculpting Lift” by expressing the two aspects of care—power and precision—through sensuous visuals. Centered on DuoTight’s unique dual-care concept, this campaign proposes a lifting solution that considers both facial contours and fine details. By combining “DUO CARE,” which provides deep and powerful lifting for broad contour areas, with “DOT CARE,” which precisely refines delicate areas such as the eyes and mouth, the campaign emphasizes the value of “Sculpting Lifting”—a treatment that goes beyond simple tightening to address both facial contours and fine details. The video will be released sequentially through major TV channels, out-of-home (OOH) advertising, YouTube, Instagram, and other platforms. A Viol Medical representative stated, “This campaign conveys the differentiated value of DuoTight—powerful contour care and precise detail care,” adding, “We will continue to expand our engagement with consumers through a variety of content.”
The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…